Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$58.75 0.58 (1.00%)
2/9/2010 4:02 PM

Allergan, Inc. (AGN)

CAPS Rating:
***

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AGN

Add Stock to Watchlist

What the Community Thinks

Total Members

334 Outperforms
24 Underperforms
 

All-Stars

95 Outperforms
5 Underperforms
 

Wall Street

14 Outperforms
1 Underperforms
 

Members bullish on AGN are also bullish on:

Members bearish on AGN are also bearish on:

Ticker Tags

Six Sigma® (31), Large Cap (413), Defensive (1457), Growth (1902), Healthcare (711), S&P 500 (499), Pharmaceuticals (149)
Suggest a tag

Allergan, Inc. At A Glance

Current Price: $58.75
Last Trade Time: 2/9/2010 4:02 PM
Open: $58.65
Previous Close: $58.17
Daily Range: $58.27 - $59.35
52-Week Range: $35.41 - $64.08
Volume: 2,336,104
Market Cap: $18.07B
P/E Ratio: 20.77
Compare Our Special Broker Offers!

Stock Trends

AGN VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Allergan, Inc. (AGN)

Avatar boater9384 (23.57) Submitted: 2/12/08 10:01 AM

Botox is huge and this stock just took its biggest dive in three years last Friday. Going to go up from here; 12-month forecast price is around $75.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Allergan, Inc. (AGN)

Avatar jbparis1 (< 20) Submitted: 1/30/08 8:56 PM

Allergan has too much liability with Botox. The recent deaths that are supposedly connected to injections will cause more problems for Allergan. The use of Botox will continue to grow for the next year, but legal issues will drain investor confidence and pave the way for class action lawsuits.
Als...More

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 48 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AGN)

Avatar foolontherocks (71.18) Submitted: 12/18/09 1:24 AM : Outperform Start Price: $60.41 AGN Score: -0.04

botox will stay popular

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar craigliles (55.90) Submitted: 11/13/09 3:42 PM : Underperform Start Price: $60.02 AGN Score: -0.36

Gap down to 48

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar 00100 (96.16) Submitted: 7/30/09 2:43 PM : Outperform Start Price: $52.45 AGN Score: 3.00

Upthumb. Kind of pricey. But good growth rate. Excellent balance sheet. Low debt ratio. Good payout. Good cash flow.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar COOLSTOCK (68.71) Submitted: 6/12/09 11:00 AM : Outperform Start Price: $45.61 AGN Score: 14.21

good company

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar akdag (< 20) Submitted: 2/26/09 10:31 AM : Outperform Start Price: $40.88 AGN Score: 12.98

Very successful product line with not much comparable competition (Botox, Juvederm). They also developed less expensive and evasive procedures like eye lash treatments. Especially during tough eco times personal (and more affordable) luxuries like the lash and various derma treatments will allow revenue targets being met. AGN will be doing fine b/c of the current economy.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 48 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 15 of 15  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBreanMurray 86.47 12/17/09 Outperform NS $60.47-2.84%-3.16%+0.32
TrackTobinSmith < 20 11/20/09 Outperform 1Y $58.62+0.22%-2.02%+2.24
TrackCanaccord 86.15 10/01/09 Outperform NS $57.15+2.80%+0.81%+1.99
TrackCitigroup 85.92 07/20/09 Outperform NS $48.49+21.15%+13.78%+7.37
TrackSunTrustRH 87.33 06/10/09 Outperform NS $44.44+32.20%+13.47%+18.72
TrackTWeisel < 20 06/02/09 Outperform NS $44.83+31.05%+14.77%+16.28
TrackPiperJaff 85.79 03/12/09 Outperform NS $38.46+52.75%+50.25%+2.50
TrackCreditSuiss 93.62 02/25/09 Outperform NS $39.10+50.26%+41.44%+8.82
TrackEdwardOwens 98.91 06/13/08 Outperform 1Y $56.46+4.06%-17.33%+21.39 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 90.73 09/30/07 Outperform NS $63.91-8.08%-26.38%+18.30 Toggle the visibility of 60-Second Pitch and replies
TrackWellsFargo 80.02 07/11/07 Outperform NS $57.65+1.91%-25.13%+27.04
TrackLazardCapit < 20 05/29/07 Outperform NS $61.01-3.70%-25.55%+21.85
TrackMatrix 90.36 05/24/07 Underperform NS $59.71-1.61%-25.69%-24.08
TrackBofASec 94.61 11/20/06 Outperform NS $57.99+1.31%-18.85%+20.16
TrackJimCramer < 20 09/05/06 Outperform 3W $56.18+4.57%-13.24%+17.81

Results 1 - 15 of 15  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 343ms